chr5-112828864-G-A

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP7BA1BP4

This summary comes from the ClinGen Evidence Repository: The c.1635G>A (p.Ala545=) variant is a synonymous (silent) variant that is not predicted to impact splicing (BP4, BP7). The highest population minor allele frequency in gnomAD v2.1.1 is 0.82 (15756 in 19198 alleles) in the East Asian population, which is higher than the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (HCCP VCEP) threshold (≥ 0.001) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as Benign for FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: BA1, BP4, and BP7. (VCEP specifications version 1; date of approval: 12/12/2022). LINK:https://erepo.genome.network/evrepo/ui/classification/CA005411/MONDO:0021056/089

Frequency

Genomes: 𝑓 0.60 ( 27988 hom., cov: 33)
Exomes 𝑓: 0.63 ( 289133 hom. )

Consequence

APC
NM_000038.6 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel B:19O:1

Conservation

PhyloP100: 1.61
Variant links:
Genes affected
APC (HGNC:583): (APC regulator of WNT signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BP7
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
APCNM_000038.6 linkuse as main transcriptc.1635G>A p.Ala545Ala synonymous_variant 14/16 ENST00000257430.9 NP_000029.2 P25054-1Q4LE70

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
APCENST00000257430.9 linkuse as main transcriptc.1635G>A p.Ala545Ala synonymous_variant 14/165 NM_000038.6 ENSP00000257430.4 P25054-1
ENSG00000258864ENST00000520401.1 linkuse as main transcriptn.120G>A non_coding_transcript_exon_variant 3/83 ENSP00000454861.1 H3BNH8

Frequencies

GnomAD3 genomes
AF:
0.601
AC:
91390
AN:
151970
Hom.:
27971
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.534
Gnomad AMI
AF:
0.614
Gnomad AMR
AF:
0.669
Gnomad ASJ
AF:
0.566
Gnomad EAS
AF:
0.819
Gnomad SAS
AF:
0.732
Gnomad FIN
AF:
0.536
Gnomad MID
AF:
0.623
Gnomad NFE
AF:
0.613
Gnomad OTH
AF:
0.613
GnomAD3 exomes
AF:
0.649
AC:
162952
AN:
250988
Hom.:
53916
AF XY:
0.649
AC XY:
88028
AN XY:
135684
show subpopulations
Gnomad AFR exome
AF:
0.532
Gnomad AMR exome
AF:
0.733
Gnomad ASJ exome
AF:
0.581
Gnomad EAS exome
AF:
0.822
Gnomad SAS exome
AF:
0.714
Gnomad FIN exome
AF:
0.559
Gnomad NFE exome
AF:
0.619
Gnomad OTH exome
AF:
0.649
GnomAD4 exome
AF:
0.628
AC:
911919
AN:
1453172
Hom.:
289133
Cov.:
31
AF XY:
0.630
AC XY:
455355
AN XY:
723316
show subpopulations
Gnomad4 AFR exome
AF:
0.518
Gnomad4 AMR exome
AF:
0.726
Gnomad4 ASJ exome
AF:
0.581
Gnomad4 EAS exome
AF:
0.840
Gnomad4 SAS exome
AF:
0.710
Gnomad4 FIN exome
AF:
0.572
Gnomad4 NFE exome
AF:
0.616
Gnomad4 OTH exome
AF:
0.633
GnomAD4 genome
AF:
0.601
AC:
91459
AN:
152088
Hom.:
27988
Cov.:
33
AF XY:
0.603
AC XY:
44816
AN XY:
74320
show subpopulations
Gnomad4 AFR
AF:
0.534
Gnomad4 AMR
AF:
0.669
Gnomad4 ASJ
AF:
0.566
Gnomad4 EAS
AF:
0.819
Gnomad4 SAS
AF:
0.732
Gnomad4 FIN
AF:
0.536
Gnomad4 NFE
AF:
0.613
Gnomad4 OTH
AF:
0.610
Alfa
AF:
0.610
Hom.:
35610
Bravo
AF:
0.610
Asia WGS
AF:
0.754
AC:
2619
AN:
3476
EpiCase
AF:
0.610
EpiControl
AF:
0.612

ClinVar

Significance: Benign
Submissions summary: Benign:19Other:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:8
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo Clinic-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 16, 2016- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 01, 2008- -
Familial adenomatous polyposis 1 Benign:4
Benign, reviewed by expert panelcurationClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert PanelFeb 19, 2023The c.1635G>A (p.Ala545=) variant is a synonymous (silent) variant that is not predicted to impact splicing (BP4, BP7). The highest population minor allele frequency in gnomAD v2.1.1 is 0.82 (15756 in 19198 alleles) in the East Asian population, which is higher than the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (HCCP VCEP) threshold (0.001) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as Benign for FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: BA1, BP4, and BP7. (VCEP specifications version 1; date of approval: 12/12/2022). -
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingCounsylMay 03, 2016- -
Hereditary cancer-predisposing syndrome Benign:3
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMar 18, 2016- -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 22, 2014This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, no assertion criteria providedclinical testingInstitute for Biomarker Research, Medical Diagnostic Laboratories, L.L.C.Dec 21, 2021- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Carcinoma of colon Benign:1
Benign, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The c.1635G>A, p.Ala545Ala silent variant, located in exon 14 of APC, is not expected to have clinical significance because it does not alter an amino acid residue, is 9 bp away from the nearest splice junction, is listed in dbSNP (rs_id: rs351771) with a heterozygosity frequency of 0.479+/-0.099. Based on the above information, this is a likely benign variant. -
APC-Associated Polyposis Disorders Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Familial colorectal cancer Other:1
other, no assertion criteria providedliterature onlySystems Biology Platform Zhejiang California International NanoSystems Institute-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
14
DANN
Benign
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs351771; hg19: chr5-112164561; COSMIC: COSV57321606; API